Ipamorelin: Reported Benefits, Side Effects and the State of the Evidence
Also referenced as: Growth hormone secretagogue receptor agonist
A literature-led overview of Ipamorelin — what has actually been measured in the published record, what remains unknown, and how research-grade material is characterised.
4 min read · Literature review · Updated 2026
Research-grade Ipamorelin vials — ≥99% HPLC purity, lot-matched COA on request, from $39.99.
Shop IpamorelinWhat Ipamorelin is
A selective ghrelin/GHS-R1a receptor agonist pentapeptide used in growth-axis receptor research.
Research material is supplied as a lyophilised powder in a sealed vial, reconstituted with bacteriostatic water immediately before use and characterised by reverse-phase HPLC with identity confirmed by mass spectrometry. The published record for Ipamorelin is dominated by preclinical sources, which is the most important caveat when reading any summary of its reported effects.
Reported benefits of Ipamorelin in the literature
The areas below summarise what published work has actually measured. Each is an observation reported in the cited literature — not a claimed outcome, and not a statement of efficacy in humans.
Secretagogue research
Animal and in-vitro work has investigated GH-axis signalling selectivity.
How it is described mechanistically
Mechanistic descriptions of Ipamorelin in the literature centre on the pathways below. Pathway attributions should be read as proposed rather than settled.
GHS-R1a agonism
Described as a selective ghrelin receptor agonist with limited cross-activity in receptor panels. Pathway noted in the literature: GHS-R1a → Gq → PLC → IP3/Ca²⁺.
Ipamorelin side effects and safety data gaps
Human safety data are limited; not established for human use.
No consistent adverse-event profile has been established for Ipamorelin. The meaningful limitation is absence of data rather than a documented list of effects.
Open data gaps: controlled human trials. Peptide Lounge does not publish dosing or administration guidance for any compound, and this material is not for human or veterinary use.
Purity, testing and handling for research use
Every Ipamorelin lot is released at ≥99% purity by RP-HPLC with identity confirmed by ESI-MS, and a lot-matched certificate of analysis is available on request rather than a generic sample document.
Vials ship lyophilised and sealed, and are stable at ambient temperature during transit. Store unreconstituted vials refrigerated and protected from light; once reconstituted, keep refrigerated and treat the solution as short-dated. Experimental concentrations must be determined by the researcher from the peer-reviewed literature under their own institutional protocol.
How researchers source Ipamorelin
Ipamorelin is stocked as a 10mg single-compound vial, with volume pricing applied automatically to multi-vial orders. Free bacteriostatic water and research supplies are included on qualifying orders.
Related research vials
Ipamorelin — frequently asked questions
What are the reported benefits of Ipamorelin?
Published work describes secretagogue research. These findings come from preclinical or in-vitro studies rather than controlled human trials.
What side effects have been reported for Ipamorelin?
No established adverse-event profile exists. The substantive limitation is missing data: controlled human trials.
Is Ipamorelin approved for human use?
No. Ipamorelin supplied by Peptide Lounge is a laboratory reagent for in-vitro and laboratory research only. It is not an approved drug and is not for human or veterinary use.
How is Ipamorelin stored and reconstituted?
Store lyophilised vials refrigerated and protected from light. Reconstitute with bacteriostatic water immediately before use and keep the resulting solution refrigerated. Vials remain stable at ambient temperature during shipping.
How do I verify the purity of a Ipamorelin vial?
Request the lot-matched certificate of analysis for the batch you received. It reports RP-HPLC purity (≥99%) and ESI-MS identity confirmation for that specific lot.
Research areas
Secretagogue research
Preclinical dataAnimal and in-vitro work has investigated GH-axis signalling selectivity.
Mechanisms of action (as described in literature)
GHS-R1a agonism
Preclinical dataDescribed as a selective ghrelin receptor agonist with limited cross-activity in receptor panels.
GHS-R1a → Gq → PLC → IP3/Ca²⁺
Published studies
No peer-reviewed study links are curated for this compound yet. Available information is limited to analytical and preclinical sources. Absence of linked studies should be read as an evidence gap.
Safety signals & data gaps
Reported signals only — safety is not established
Human safety data are limited; not established for human use.
Known data gaps: Controlled human trials.
For Research Use Only
All products listed are supplied strictly as laboratory reagents for in-vitro research and analytical work conducted by qualified professionals. They are not drugs, foods, cosmetics or medical devices, and must not be administered to humans or animals. No product on this site is approved by the FDA for human use.
Research Use Only: Products are sold strictly for laboratory research and educational purposes only. Not for human consumption, veterinary use, food use, cosmetic use, or therapeutic application. Products are not intended to diagnose, treat, cure, or prevent any disease.